ABVC BioPharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(9.9%),Lind Global Partners II LLC(9.9%), etc.
ABVC BioPharma | D: Filing D
ABVC BioPharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(9.9%),Lind Global Partners II LLC(9.9%), etc.
ABVC BioPharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lind Global Fund II LP(9.9%),Lind Global Partners II LLC(9.9%), etc.
ABVC BioPharma | D: Filing D
ABVC BioPharma | 3: Initial statement of beneficial ownership of securities-Director Jiang Shuling
ABVC BioPharma | SC 13D: Statement of acquisition of beneficial ownership by individuals-Shuling Jiang(24.5%)
ABVC BioPharma | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer An Chihliang
ABVC BioPharma | 3: Initial statement of beneficial ownership of securities
ABVC BioPharma | 3: Initial statement of beneficial ownership of securities
ABVC BioPharma | 3: Initial statement of beneficial ownership of securities
ABVC BioPharma | 3: Initial statement of beneficial ownership of securities
ABVC BioPharma | 3: Initial statement of beneficial ownership of securities
ABVC BioPharma | 3: Initial statement of beneficial ownership of securities
ABVC BioPharma | 3: Initial statement of beneficial ownership of securities
ABVC BioPharma | 3: Initial statement of beneficial ownership of securities
ABVC BioPharma | 3: Initial statement of beneficial ownership of securities
ABVC BioPharma | 3: Initial statement of beneficial ownership of securities
ABVC BioPharma | 3: Initial statement of beneficial ownership of securities
ABVC BioPharma | D: Filing D